MeiraGTx Holdings (MGTX) Share-based Compensation Growth (1y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | -8.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.44% |
| Sep 30, 2025 | -5.58% |
| Jun 30, 2025 | -2.45% |
| Mar 31, 2025 | -29.78% |
| Dec 31, 2024 | -12.11% |
| Sep 30, 2024 | -10.62% |
| Jun 30, 2024 | -20.15% |
| Mar 31, 2024 | 8.21% |
| Dec 31, 2023 | 2.28% |
| Sep 30, 2023 | 1.67% |
| Jun 30, 2023 | -0.44% |
| Mar 31, 2023 | -15.12% |
| Dec 31, 2022 | 25.44% |
| Sep 30, 2022 | 29.93% |
| Jun 30, 2022 | 40.36% |
| Mar 31, 2022 | 57.32% |
| Dec 31, 2021 | 37.69% |
| Sep 30, 2021 | 42.83% |
| Jun 30, 2021 | 2.91% |
| Mar 31, 2021 | -15.24% |
| Dec 31, 2020 | -22.78% |
| Sep 30, 2020 | 6.63% |
| Jun 30, 2020 | 15.27% |
| Mar 31, 2020 | 93.63% |
| Dec 31, 2019 | 119.20% |
| Sep 30, 2019 | 2.94% |
| Jun 30, 2019 | -32.85% |
| Mar 31, 2019 | -31.36% |
| Dec 31, 2018 | 214.84% |
| Sep 30, 2018 | 569.23% |
| Jun 30, 2018 | 857.55% |